Travaux scientifiques

Prof. Dr. Evren Özdemir

153 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Özdemir E, Basu S, Blough RI, Winkelmann JC. Description of human and murine CD44 homologs; human HAR (hHAR) and murine HAR (mHAR). Turkish Journal of Cancer, 34, 60-66, 2004.

    Source : page de profil sur medicana.com.tr

  2. Dönmez A, Çal Ç, Hekimgil M, Çağırgan S, Şencan M, Özdemir E, Özyurt C, Çıkılı N, Göker E. Prostatic involvement of non-hodgkin lymphoma: Case report. Medical Journal of Ege University, 7, 41-43, 1997.

    Source : page de profil sur medicana.com.tr

  3. Göker E, Özdemir E. Tümör belirteçleri. Spektrum Derlemeler, sf. 19-27, ed. Kaya Emerk, Açılım Yayıncılık, İzmir, 1997.

    Source : page de profil sur medicana.com.tr

  4. Cirit M, Arkun R, Özbek S, Sermez Y, Saydam G, Özdemir E, Töbü M, Başçı A. Ağır sekonder hiperparatiroidili iki üremik hastada perkütanöz ince iğne ethanol enjeksiyonu. Ulusal Endokrinoloji Dergisi, 6, 419-425, 1996.

    Source : page de profil sur medicana.com.tr

  5. Özdemir E, Sebik F. Bronşiyel astımın etiopatojenezi. Akademi, 2, 85-103, 1996.

    Source : page de profil sur medicana.com.tr

  6. Cirit M, Özkahya M, Özdemir E, Başçı A, Atabay G. İki hemodiyaliz hastasında kardiyak tamponadla seyreden pürülan perikardit. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, 5, 40-42, 1996.

    Source : page de profil sur medicana.com.tr

  7. Saydam G, Cirit M, Özdemir E, Akçiçek F, Atabay G. Metabolik asidoz: kronik böbrek yetmezliğinde anlamlı bir katabolik faktör. SSK İzmir Eğitim Hastanesi Tıp Dergisi, 1, 39-40, 1995.

    Source : page de profil sur medicana.com.tr

  8. Özdemir E, Akçiçek F. Renal transplantasyonda immünosupresif tedavi. Akademi, 2, 79-96, 1995.

    Source : page de profil sur medicana.com.tr

  9. Ok E, Özdemir E, Akçiçek F, Yönetçi N, Töbü M, Cirit M, Atabay G, Batur Y. Hemodiyaliz Ünitesinde HBV ve HCV enfeksiyonu prevelansındaki değişiklikler. T Klin Gastroenterohepatoloji, 5, 188-191, 1994.

    Source : page de profil sur medicana.com.tr

  10. Ok E, Töbü M, Özdemir E, Akçiçek F, Tokat Y, Bor S, Atabay G, Batur Y. Renal allograft alıcılarında HBV, HCV ve HDV enfeksiyonları. Gastroenteroloji, 5, 642-646, 1994.

    Source : page de profil sur medicana.com.tr

  11. Özdemir E, Turker A, Barısta I, Kars A. The lollipop with strawberry aroma significantly reduces infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells: A randomized study. Submitted to Biol Blood Marrow Transplant, 2020.

    Source : page de profil sur medicana.com.tr

  12. Özdemir E, Turker A, Barısta I, Kars A. Gemcitabine in combination with oxaliplatin (GemOx) as a salvage regimen in patients with relapsed/refractory Hodgkin’s lymphoma. Submited to Clinical Lymphoma, Myeloma & Leukemia, 2020.

    Source : page de profil sur medicana.com.tr

  13. Özdemir E, Turker A, Barısta I, Kars A. Weekly Paclitaxel and Carboplatin as a salvage regimen in patients with relapsed/refractory Hodgkin’s lymphoma. Submited to Leukemia & Lymphoma, 2020.

    Source : page de profil sur medicana.com.tr

  14. Özbalak M, Salihoğlu A, Soysal T, Karadoğan İ, Paydaş S, Özdemir E, Yıldız B, Karadurmuş N, Kaynar L, Yagci M, Özkocaman V, Topçuoğlu P, Özcan M, Birtaş E, Göker H, Ferhanoglu B. Long term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience. Ann Hematol. 99(2):301-307, 2020.

    Source : page de profil sur medicana.com.tr

  15. Okay M, Aslan T, Özdemir E, Uner A, Saglam A, Gungor E, Uysal A, Alayvaz Aslan N, Yildizhan E, Agit A, Dal MS, Korkmaz S, Namdaroglu S, Sivgin S, Akgun Cagliyan G, Demircioglu S, Barista I, Ozhamam E, Vural F, Eser B, Ozet G, Yildirim R, Dogu MH, Berber I, Erkurt MA, Malkan UY, Altuntas F, Buyukasik Y. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor-Multicenter Cohort Study. Turkish Journal of Hematology Oct. 21, 2019.

    Source : page de profil sur medicana.com.tr

  16. Aerts-Kaya F, Koca G, Sharafi P, Sayla FC, Akbiyik F, Uckan-Cetinkaya D, Özdemir E. Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+ cell numbers. Bone Marrow Transplant. 53(9):1225-1227, 2018.

    Source : page de profil sur medicana.com.tr

  17. Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Brentuximab Vedotin with Chemotherapy for Stage III and IV Hodgkin’s Lymphoma. N Engl J Med. 378(4):331-344, 2018. Aslan A, Arat T, Özdemir E. Successful Treatment of Relapsed/Refractory Hodgkin’s Lymphoma with Nivolumab in a Heavily Pretreated Patient with Progressive Disease after Both Autologous and Allogeneic Stem Cell Transplantation. Leuk Lymphoma. 58(3):754-755, 2017.

    Source : page de profil sur medicana.com.tr

  18. Sarici F, Kertmen N, Aslan A, Tasdemir V, Babacan T, Kilickap S, Özdemir E, Barista I, Turker A, Kars A. Antracyclin-Based Chemotherapy in Patients with Non-Hodgkin’s Lymphoma Aged over 75. International Journal of Hematology and Oncology 26(2):1-7, 2016.

    Source : page de profil sur medicana.com.tr

  19. Tekgunduz E, Goker H, Kaynar L, Sarı I, Pala C, Dogu MH, Ozturk E, Turgut B, Korkmaz S, Tetik A, Buyukasık Y, Hacıoglu SK, Bozdag SC, Özdemir E, Altuntas F. Adult Philadelphia chromosome-positive acute lymphoblastic leukemia in daily practice: A multicenter experience. Clin Lymphoma Myeloma Leuk. 16(5):269-274, 2016.

    Source : page de profil sur medicana.com.tr

  20. Aksu A, Ayyildiz O, Etgul S, Goker H, Gunes G, Haznedaroglu IC, Ilhan O, Kaynar LG, Malkan UY, Özdemir E, Saydam G, Sayinalp N, Sahin F, Turgut M, Unal A. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders. International Journal of Hematology and Oncology 26(2): 12-19, 2016.

    Source : page de profil sur medicana.com.tr

  21. Salihoglu A, Elverdi T, Karadogan I, Paydas S, Özdemir E, Erdem G, Karadurmuş N, Akyol G, Kaynar L, Yegin ZA, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Goker H, Baslar Z, Ferhanoglu B. Bretuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. Ann Hematol. 94(3):415-20, 2015.

    Source : page de profil sur medicana.com.tr

  22. Bayraktar-Ekincioglu A, Demirkan K, Keskin B, Aslantaş O, Özdemir E. Potential drug interactions and side effects in an outpatient oncology clinic: a retrospective descriptive study. Eur J Hosp Pharm 21:216-221, 2014.

    Source : page de profil sur medicana.com.tr

  23. Ayyıldız O, Demirkan F, Goker H, Haznedaroglu IC, Ilhan O, Kaynar LG, Özdemir E, Saydam G, Sayınalp N, Sahin F, Turgut M, Unal A, Vural F. Ibrutinib: From molecule to medicine. International Journal of Hematology and Oncology 3(1):24, 2014.

    Source : page de profil sur medicana.com.tr

  24. Goker H, Özdemir E, Uz B, Buyukasik Y, Turgut M, Serefhanoglu S, Aksu S, Sayinalp N, Haznedaroglu IC, Tekin F, Karacan Y, Unal S, Eliacik E, Isik A, Ozcebe OI. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience. Transfus Apher Sci. August 8, 2013.

    Source : page de profil sur medicana.com.tr

  25. Buyukasik Y, Acar K, Kelkitli E, Uz B, Serefhanoglu S, Özdemir E, Pamukcuoglu M, Atay H, Bektas O, Sucak GT, Turgut M, Aksu S, Yagci M, Sayınalp N, Ozcebe OI, Goker H, Haznedaroglu IC. Hyper-CVAD regimen in routine management of adult lymphoblastic leukemia: A retrospective multicenter study. Acta Haematologica 130:199-205, 2013.

    Source : page de profil sur medicana.com.tr

  26. Özdemir E, Kansu E. Deep vein thrombosis following non-myeloablative allogeneic stem cell transplantation: Presentation of three cases and literature review. Turkish Journal of Hematology 30:188-190, 2013.

    Source : page de profil sur medicana.com.tr

  27. Camurdanoglu BZ, Esendaglı G, Özdemir E, Canpınar H, Guc D, Kansu E. The effect of granulocyte colony stimulating factor receptor gene missense single nucleotide polymorphisms on peripheral blood stem cell enrichment. Cytokine Nov 15, 2012.

    Source : page de profil sur medicana.com.tr

  28. Uz B, Özdemir E, Aksu S, Akyol TK, Jones R. Successful treatment of autoimmune hemolytic anemia with steroid, IVIG, and plasmapheresis in a haploidentical transplant recipient. Turkish Journal of Hematology 29:199-200, 2012.

    Source : page de profil sur medicana.com.tr

  29. Arslan C, Özdemir E, Dogan E, Ozisik Y, Altundag K. Secondary hematological malignancies after treatment of non-metastatic breast cancer. Journal of BUON 16:744-750, 2011.

    Source : page de profil sur medicana.com.tr

  30. Ozmen F, Ozmen MM, Özdemir E, Moran M, Seckin S, Guc D, Karaagaoglu E, Kansu E. Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer. World J. Gastroenterol. 17(27):3220-8, 2011. Kara O, Özdemir E, Arslan C, Dogan E, Altundag K. Acute promyelocytic leukemia in a young patient with breast cancer. Med Oncol. 28(1):249-50, 2011.

    Source : page de profil sur medicana.com.tr

  31. Firat F, Ozen G, Yildiz G, Saglam A, Onder S, Tan E, Özdemir E. Late relapse of acute myeloblastic leukemia as myeloid sarcoma causing radiculopathy. Leuk Res. 34(12): e348-350, 2010.

    Source : page de profil sur medicana.com.tr

  32. Ararat E, Sahin I, Özdemir E, Altundag K. Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma. Br J Haematol. 151(5):530-531, 2010.

    Source : page de profil sur medicana.com.tr

  33. Arik Z, Ozkan C, Özdemir E, Altundag K. Breast cancer in a patient with agnogenic myeloid metaplasia. Souh Med J. 103(10):1075-1076, 2010.

    Source : page de profil sur medicana.com.tr

  34. Serefhanoglu S, Buyukasık Y, Goker H, Sayinalp N, Haznedaroglu IC, Aksu S, Ozcebe OI, Turgut M, Aslan R, Özdemir E. Clinical Features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and antracyclines (PETHEMA protocol) therapy. Leuk Res. 34(12): e317-319, 2010.

    Source : page de profil sur medicana.com.tr

  35. Özdemir E, Bayraktar M, Sokmensuer C, Kir KM, Kansu E. Late relapse of a light chain myeloma as extramedullary plasmacytoma of the thyroid gland after second allogeneic stem cell transplantation. Clinical Transplantation 23(6): 981-984, 2009.

    Source : page de profil sur medicana.com.tr

  36. Oyan B, Koc Y, Özdemir E, Kars A, Turker A, Tekuzman G, Kansu E. High complete remission rate and durable remissions achieved with rational use of autologous stem cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma. Clinical Transplantation 23(6): 839-847, 2009.

    Source : page de profil sur medicana.com.tr

  37. Özdemir E, Akgedik K, Akdogan S, Kansu E. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells. Biol Blood Marrow Transplant 14(12):1425-8, 2008.

    Source : page de profil sur medicana.com.tr

  38. Özdemir E, Saliba RM, Champlin RE, Couriel DR, Giralt SA, de Lima M, Khouri IF, Hosing C, Kornblau SM, Anderlini P, Shpall EJ, Qazilbash MH, Molldrem JJ, Chemaly RF, Komanduri KV. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplantation 40:125-136, 2007.

    Source : page de profil sur medicana.com.tr

  39. Dizdar Ö, Özdemir E, Üner A, Kansu E. Images in hematology-oncology: A 40-year-old female presenting with a solitary pulmonary nodule. Turkish Journal of Cancer 36, 35-37, 2006.

    Source : page de profil sur medicana.com.tr

  40. Oyan B, Koc Y, Özdemir E, Kars a, Turker A, Tekuzman G, Kansu E. High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma. Leukemia and Lymphoma, 47(8): 1545-1552, 2006.

    Source : page de profil sur medicana.com.tr

  41. Özdemir E, Molldrem JJ. Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia. Bone Marrow Transplantation, 37, 785-786, 2006.

    Source : page de profil sur medicana.com.tr

  42. Özdemir E, Koc Y, Kansu E. Successful treatment of chronic myeloid leukemia with imatinib mesylate in a patient with chronic renal failure on hemodialysis. American Journal of Hematology, 81(6), 474, 2006.

    Source : page de profil sur medicana.com.tr

  43. Oyan B, Koc Y, Özdemir E, Kars A, Turker A, Tekuzman G, Kansu E. Ifosfamide, Idarubicin, and Etoposide in Relapsed/Refractory Hodgkin’s Disease or Non-Hodgkin Lymphoma: A Salvage Regimen with High Response Rates before Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 11, 688-697, 2005.

    Source : page de profil sur medicana.com.tr

  44. Özdemir E, Basu S, Blough RI, Winkelmann JC: Description of human and murine CD44 homologs; human HAR (hHAR) and murine HAR (mHAR). Turkish Journal of Cancer, 34(2):60-66, 2004.

    Source : page de profil sur medicana.com.tr

  45. Özdemir E, St. John LS, Molldrem JJ, Gillespie G, Champlin RE, Rowland-Jones S, Komanduri KV. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood, 100, 3690-3697, 2002.

    Source : page de profil sur medicana.com.tr

  46. Çağırgan S, Şencan M, Tombuloğlu M, Özdemir E, Hekimgil M, Büyükkeçeci F. Two Consecutive Spontaneous Regressions to Chronic Phase in a Patient with Blastic Transformation of Chronic Myelogenous Leukemia. Leukemia and Lymphoma, 29, 423-425, 1998.

    Source : page de profil sur medicana.com.tr

  47. Kocanogulları H, Özdemir E, Keser G, Tuncbay T, Gumusdis G, Doganavsargil E. Focal Myositis. Clin Rheumatol, 17, 65-67, 1998.

    Source : page de profil sur medicana.com.tr

  48. Çağırgan S, Şencan M, Dönmez A, Özdemir E, Tombuloğlu M, Büyükkeçeci F. A case report: Chronic lymphocytic leukemia with widespread osteolytic lesions. Turkish Journal of Haematology, 14, 113-115, 1997.

    Source : page de profil sur medicana.com.tr

  49. Özdemir E. Aplastik Anemi ve Miyelodisplastik Sendromda Febril Nötropeni. Bölüm 4: Özel durumdaki immünkompromize hastalar, Febril Nötropeni, Editörler: Murat Akova, Hamdi Akan, Bilimsel Tıp Yayınevi, 2010, S:321-331.

    Source : page de profil sur medicana.com.tr

  50. Özdemir E. Kanser tedavisinin yan etkileri. Hacettepe Üniversitesi Tıp Fakültesi Sağlık Ansiklopedisi Editör: Prof. Dr. İskender Sayek, Güneş Tıp Kitabevleri, sayfa:367-369, 2008.

    Source : page de profil sur medicana.com.tr